 Antifungal surgical treatment invasive aspergillosis review cases erratum Rev Infect Dis Mar-Apr controlled trials therapy invasive aspergillosis review cases articles literature courses treatment infection various body sites patients exclusion early failures therapy results favorable outcome rate response Mortality pulmonary aspergillosis bone marrow transplant recipients regardless therapy cerebral aspergillosis hosts Amphotericin mg/ kg.d flucytosine lowers mortality neutropenic patients pulmonary aspergillosis bone marrow transplant relapse common Surgical debridement aspergillus maxillary sinusitis curative nonimmunocompromised patients mortality neutropenic patients Valve replacement essential aspergillus endocarditis vitrectomy intravitreal amphotericin treatment essential aspergillus endophthalmitis Flucytosine useful Itraconazole efficacy treatment pulmonary skeletal pericardial aspergillosis liposomal amphotericin toxic standard preparations drug relevant data proposed potentiation amphotericin rifampin unsupported clinical data conventional therapy mortality invasive aspergillosis high new approaches